{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:22:33Z","timestamp":1794248553080,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K02444"],"award-info":[{"award-number":["26K02444"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ck0106538"],"award-info":[{"award-number":["JP22ck0106538"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ck0106789"],"award-info":[{"award-number":["JP23ck0106789"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18im0210102"],"award-info":[{"award-number":["JP18im0210102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006452","name":"University of Miyazaki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016589","name":"Tokyo Metropolitan Institute of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116850","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:35:05Z","timestamp":1784820905000},"page":"116850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The requirement of MALT1 activity for the growth of adult T cell leukemia\/lymphoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Ayako","family":"Kamiunten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Ebara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotaro","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Shide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tokuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Arikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Maru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Yoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoma","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Akizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kubuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116850_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116850_bib3","series-title":"Adult T-cell leukaemia\/lymphoma","first-page":"281","year":"2008"},{"key":"10.1016\/j.isci.2026.116850_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib5","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.116850_bib6","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116850_bib7","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116850_bib9","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia\/Lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116850_bib10","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/cas.15431","article-title":"Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia\/lymphoma: Phase IIb results","volume":"113","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.116850_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2022016862","article-title":"An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma","volume":"141","author":"Izutsu","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116850_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib15","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102568","article-title":"Function and targeting of MALT1 paracaspase in cancer","volume":"117","author":"O'Neill","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.isci.2026.116850_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","article-title":"The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes","volume":"14","author":"Sun","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116850_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","article-title":"Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation","volume":"9","author":"Gewies","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116850_bib19","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.15252\/embj.201488987","article-title":"Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity","volume":"33","author":"Jaworski","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2026.116850_bib20","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.csbj.2022.08.021","article-title":"Integrating knowledge of protein sequence with protein function for the prediction and validation of new MALT1 substrates","volume":"20","author":"Bell","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.isci.2026.116850_bib21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ni.3008","article-title":"Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation","volume":"15","author":"Jeltsch","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116850_bib22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116850_bib23","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","article-title":"Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL","volume":"22","author":"Nagel","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116850_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","article-title":"MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo","volume":"22","author":"Fontan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116850_bib26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20091167","article-title":"Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells","volume":"206","author":"Ferch","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116850_bib27","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.1073\/pnas.0907511106","article-title":"Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma","volume":"106","author":"Hailfinger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116850_bib28","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","article-title":"A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains","volume":"182","author":"D\u00fcwel","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116850_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116850_bib30","doi-asserted-by":"crossref","first-page":"14576","DOI":"10.1021\/acs.jmedchem.0c01245","article-title":"Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing","volume":"63","author":"Pissot Soldermann","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.116850_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11292","article-title":"Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells","volume":"7","author":"Meininger","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116850_bib32","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1126\/science.1090769","article-title":"Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase","volume":"302","author":"Ruefli-Brasse","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116850_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","article-title":"Differential requirement for Malt1 in T and B cell antigen receptor signaling","volume":"19","author":"Ruland","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116850_bib34","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.2023021299","article-title":"Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas","volume":"142","author":"Wimberger","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib35","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood.2019002639","article-title":"Feed-forward regulatory loop driven by IRF4 and NF-kappaB in adult T-cell leukemia\/lymphoma","volume":"135","author":"Wong","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1095257","article-title":"CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1(+) ICOS(high) activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells","volume":"14","author":"Masle-Farquhar","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116850_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ejh.13467","article-title":"MALT-1 as a novel therapeutic target for adult T-cell leukemia","volume":"105","author":"Ishikawa","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.isci.2026.116850_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imcb.1018","article-title":"The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition","volume":"96","author":"Bardet","year":"2018","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.isci.2026.116850_bib39","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/j.bmc.2016.03.035","article-title":"Development of new Malt1 inhibitors and probes","volume":"24","author":"Xin","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.isci.2026.116850_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005442","article-title":"Combining precision oncology and immunotherapy by targeting the MALT1 protease","volume":"10","author":"Mempel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116850_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2507997122","article-title":"MALT1 inhibitor MI-2 induces ferroptosis by direct targeting of GPX4","volume":"122","author":"Mishima","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116850_bib42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/ejh.13474","article-title":"Clinical efficacy of mogamulizumab for relapsed\/refractory aggressive adult T-cell leukemia\/lymphoma: A retrospective analysis","volume":"105","author":"Satake","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.isci.2026.116850_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12185-025-03963-9","article-title":"Effects of tucidinostat in adult T-cell leukemia\/lymphoma in clinical practice","volume":"122","author":"Kamiunten","year":"2025","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.isci.2026.116850_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bjh.70219","article-title":"Prognostic impact of valemetostat in relapsed\/refractory adult T-cell leukaemia-lymphoma","volume":"208","author":"Shichijo","year":"2026","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.isci.2026.116850_bib45","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/jvi.65.12.6892-6899.1991","article-title":"Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation","volume":"65","author":"Arima","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.116850_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199609093442","article-title":"Features of the cytokines secreted by adult T cell leukemia (ATL) cells","volume":"21","author":"Yamada","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.isci.2026.116850_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2004.05289.x","article-title":"Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand","volume":"128","author":"Hasegawa","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.isci.2026.116850_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116850_bib49","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-08-0634","article-title":"Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels","volume":"68","author":"Morishita","year":"2008","journal-title":"Cancer Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:47:39Z","timestamp":1794246459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226022285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226022285"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116850","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The requirement of MALT1 activity for the growth of adult T cell leukemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116850"}}